The UK stock market is having a good run at the moment. This year, the FTSE 100 index has achieved all-time highs. There are still plenty of opportunities for those who like value however. Here are three cheap shares to consider this month.
A FTSE 100 bargain?
First up is healthcare giant GSK (LSE: GSK). Recent full-year 2022 results showed that the company has momentum at the moment.
For the year, the company generated sales of £29.3bn, up 13% at constant currency. Adjusted earnings per share (EPS) came in at 139.7p, up 15% year on year at constant currency.
Looking ahead, GSK wants to continue generating solid growth. For 2023, it expects turnover to rise 6-8% and EPS to increase 12-15%.
The valuation here is very undemanding however. Taking the average point of the expected EPS growth (13.5%) and applying that to last year’s earnings, the forward-looking price-to-earnings (P/E) ratio is just nine. I see value at that multiple.
Now one issue to be aware of here is Zantac litigation, with the potential to hit profits. This is probably why the stock is so cheap.
However, I think a lot of uncertainty is priced into the stock already.
Cheap as chips
Next, we have 3i Group (LSE: III), a FTSE 100 investment company that operates in the private equity and infrastructure fields.
This business is performing pretty well right now. For example, the company recently said European discount retailer Action, which is part of its private equity portfolio, generated net sales growth of 30% for the 12 months to 1 January.
The stock is super cheap though. Currently, the price-to-earnings (P/E) ratio here is just four. That seems too low to me.
It’s worth noting that 3i’s chairman David Hutchison (who has a background in investment banking) recently purchased around £230,000 worth of company shares. This got my attention. Insiders only buy stock for one reason – they expect it to rise.
I’ll point out that 3i’s revenues and profits tend to fluctuate. Next year, revenue is expected to fall. Bur I’m encouraged by the recent insider buying and I still see value on offer.
Big dividend increase
Finally, check out DS Smith (LSE: SMDS). It’s a packaging company that specialises in sustainable solutions.
This is another company that appears to be doing quite well at the moment. For the first half of its current financial year (ending 30 April), it generated constant currency revenue growth of 26%.
What stands out to me here is that the company raised its H1 dividend by a huge 25% (the yield is around 5% at the moment). This suggests management is confident about the future.
The stock can be picked up at a low valuation though. Currently, DS Smith has a forward-looking P/E ratio of just eight.
One issue to be aware of here is that packaging is a cyclical industry. So a prolonged economic downturn could hurt the company.
However, in the long run, DS Smith looks set to enjoy tailwinds from both the growth of online shopping and the increasing focus on sustainability. So I think it’s worth a closer look right now.
The post 3 cheap shares for UK investors to consider in March appeared first on The Motley Fool UK.
Should you buy Gsk shares today?
Before you decide, please take a moment to review this first.
Because my colleague Mark Rogers – The Motley Fool UK’s Director of Investing – has released this special report.
It’s called ‘5 Stocks for Trying to Build Wealth After 50’.
And it’s yours, free.
Of course, the decade ahead looks hazardous. What with inflation recently hitting 40-year highs, a ‘cost of living crisis’ and threat of a new Cold War, knowing where to invest has never been trickier.
And yet, despite the UK stock market recently hitting a new all-time high, Mark and his team think many shares still trade at a substantial discount, offering savvy investors plenty of potential opportunities to strike.
That’s why now could be an ideal time to secure this valuable investment research.
Mark’s ‘Foolish’ analysts have scoured the markets low and high.
This special report reveals 5 of his favourite long-term ‘Buys’.
Please, don’t make any big decisions before seeing them.
setButtonColorDefaults(“#5FA85D”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43A24A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#FFFFFF”, ‘color’, ‘#FFFFFF’);
- Best British shares to buy in March
- Why I’d buy these 2 no-brainer income stocks today
- Was I dumb to sell my GSK shares?
- Top British dividend stocks to buy for February
- 2 shares to buy in February for healthy dividends
Edward Sheldon has no position in any of the shares mentioned. The Motley Fool UK has recommended DS Smith and GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.